influenza
viru
famili
orthomyxovirida
respiratori
syncyti
viru
rsv
famili
pneumovirida
singlestrand
rna
virus
caus
upper
lower
respiratori
tract
infect
children
adult
influenza
viru
rsv
spread
droplet
contact
transmiss
therefor
nosocomi
acquisit
may
occur
due
exposur
anoth
infect
patient
visitor
healthcar
worker
hcw
well
contact
contamin
inanim
surfac
immunocompromis
patient
underli
hematooncolog
disord
cancer
risk
increas
mortal
especi
case
lower
respiratori
tract
infect
due
virus
commun
nosocomi
acquisit
influenza
rsv
possibl
patient
group
nosocomi
outbreak
oncolog
care
facil
describ
spite
multipl
infect
control
measur
prevent
nosocomi
transmiss
measur
includ
stringent
hand
hygien
patient
isol
use
barrier
precaut
surgic
mask
vaccin
influenza
local
nosocomi
cluster
rsv
clinic
winter
season
introduc
rtpcrbase
screen
asymptomat
patient
rsv
influenza
viru
contribut
success
control
rsv
cluster
strengthen
exist
infect
control
measur
hematolog
oncolog
subsequ
implement
systemat
influenza
rsv
screen
patient
lack
respiratori
symptom
pediatr
adult
hematooncolog
ward
prophylact
infect
control
measur
follow
winter
screen
intend
identifi
patient
shed
rsv
influenza
viru
without
sign
diseas
case
posit
screen
test
establish
infect
control
measur
similar
use
typic
symptomat
eg
cough
sneez
fever
respiratori
distress
patient
rsv
influenza
paper
describ
laboratori
result
prophylact
screen
program
asymptomat
patient
season
discuss
valu
infect
control
hematolog
oncolog
screen
program
rsv
influenza
implement
two
ward
locat
depart
pediatr
hematolog
oncolog
depart
hematolog
hemostasi
oncolog
stem
cell
transplant
hannov
medic
school
depart
tertiari
referr
center
children
adult
respect
hematolog
solid
neoplasia
pediatr
ward
contain
singl
oneb
twobe
room
adult
ward
singl
oneb
room
twobe
room
fourb
room
singl
room
pediatr
ward
singl
room
adult
ward
anteroom
higheffici
particul
air
filtrat
air
flow
direct
hallway
singl
room
usual
reserv
patient
sever
immunosuppress
palli
set
ward
servic
perman
healthcar
worker
hcw
housekeep
staff
parent
allow
stay
overnight
children
pediatr
ward
stay
ward
parent
permit
wear
street
cloth
howev
regular
chang
cloth
recommend
pcrbase
season
screen
rsv
influenza
start
second
half
decemb
end
begin
april
start
finish
screen
period
set
jointli
infect
control
staff
virologist
clinician
involv
base
avail
epidemiolog
data
adult
ward
screen
perform
upon
admiss
admiss
screen
weekli
preval
screen
pediatr
ward
pcrbase
screen
perform
weekli
respiratori
materi
obtain
patient
lack
respiratori
symptom
asymptomat
patient
prophylact
preval
screen
continu
long
patient
stay
ward
patient
symptom
respiratori
diseas
eg
cough
sneez
fever
oxygen
need
symptomat
patient
receiv
full
diagnost
virolog
panel
includ
influenza
viru
rsv
respiratori
virus
human
metapneumoviru
adenoviru
parainfluenza
viru
coronaviru
rhinoenteroviru
order
guarante
high
adher
screen
program
repeat
audit
feedback
talk
took
place
specimen
collect
combin
nasopharyng
swab
pharyng
lavag
oral
wash
steril
salin
process
institut
virolog
realtim
rtpcr
rna
extract
use
qiaamp
viral
rna
mini
kit
qiacub
accord
manufactur
instruct
qiagen
hilden
germani
cdna
synthesi
amplif
detect
nucleic
acid
perform
appli
realtim
pcr
system
life
technolog
carlsbad
california
usa
use
commerci
avail
onestep
realtim
rtpcr
kit
rsvhmpv
pcr
kit
germani
accord
manufactur
instruct
influenza
ab
multiplex
real
time
rtpcr
influenza
rtpcr
differenti
type
b
semiquantit
comparison
viral
load
followup
specimen
cycl
threshold
ct
valu
real
time
pcr
use
decreas
ct
valu
usual
equival
increas
viral
load
consid
signific
increas
viral
load
infect
control
recommend
asymptomat
infect
patient
rsv
influenza
viru
symptomat
patient
label
electron
alert
system
recommend
patient
place
singl
oneb
room
posit
pcr
test
electron
commun
infect
control
staff
contact
droplet
precaut
surgic
mask
gown
glove
mandatori
hcw
visitor
enter
room
affect
patient
patient
restrict
singl
oneb
room
train
hand
hygien
leav
room
wore
surgic
mask
two
neg
rtpcr
result
minimum
interv
requir
stop
isol
precaut
hcw
strongli
encourag
let
vaccin
influenza
winter
season
vaccin
rate
among
hcw
influenza
pediatr
ward
percent
adult
ward
decemb
april
asymptomat
patient
screen
patient
age
younger
screen
pediatr
ward
remain
adult
patient
receiv
swab
emerg
ward
wherea
patient
screen
exclus
adult
hematooncolog
ward
overal
screen
sampl
obtain
pediatr
patient
adult
mean
screen
sampl
number
per
patient
pediatr
patient
adult
major
screen
sampl
nasopharyng
swab
sampl
pharyng
wash
exclus
obtain
adult
patient
altogeth
asymptomat
patient
test
posit
either
influenza
rsv
screen
sampl
ie
combin
detect
rate
patient
adult
one
child
test
posit
influenza
type
patient
adult
children
test
posit
rsv
coinfect
influenza
viru
rsv
detect
overview
shown
tabl
tab
interestingli
patient
influenza
viru
patient
rsv
patient
signific
increas
viral
load
sampl
observ
follow
posit
screen
specimen
tabl
tab
asymptomat
patient
two
fourb
room
time
screen
test
report
posit
posit
rsv
posit
influenza
viru
patient
share
room
immedi
move
separ
singl
room
follow
infect
control
recommend
patient
influenza
kept
togeth
occupi
room
simultan
test
posit
patient
rsv
patient
influenza
stay
share
room
patient
alreadi
discharg
test
result
becam
avail
asymptomat
patient
alreadi
locat
singl
oneb
room
reason
infect
control
remain
room
viru
detect
patient
identifi
whether
locat
privat
share
room
posit
test
result
avail
barrier
precaut
droplet
contact
implement
describ
see
materi
method
section
ward
patient
present
symptom
acut
respiratori
infect
routin
test
broad
panel
respiratori
virus
includ
rsv
influenza
patient
symptom
acut
respiratori
infect
found
influenza
case
rsv
case
pediatr
ward
influenza
case
rsv
case
adult
ward
decemb
april
preval
respiratori
virus
low
season
two
ward
parainfluenza
case
human
metapneumoviru
case
rhinoviru
case
found
pediatr
ward
adult
ward
parainfluenza
case
detect
cluster
nosocomi
transmiss
rsv
influenza
observ
screen
program
period
respiratori
tract
infect
caus
rsv
influenza
viru
signific
healthcar
risk
hospit
nonhospit
patient
underli
hematooncolog
diseas
winter
season
acquisit
virus
typic
occur
commun
patient
may
admit
symptom
infect
infect
hospit
nosocomi
acquisit
due
transmiss
occur
well
recommend
suggest
control
spread
influenza
rsv
healthcar
set
gener
especi
hematooncolog
patient
exist
eg
adapt
hospit
specif
need
extend
exist
standard
infect
control
measur
introduc
prophylact
screen
program
asymptomat
patient
target
rsv
influenza
adult
pediatr
hematooncolog
ward
screen
intend
detect
patient
shed
viru
without
sign
symptom
diseas
shed
occur
onset
diseas
incub
period
asymptomat
clinic
cours
follow
diseas
result
prolong
viral
shed
particularli
immunocompromis
host
group
asymptomat
patient
often
remain
unnot
contribut
nosocomi
spread
asymptomat
shedder
detect
increas
viral
load
patient
followup
specimen
see
tabl
tab
like
patient
incub
period
group
patient
particular
interest
infect
control
strategi
sinc
increas
viral
load
risk
transmiss
also
rise
identifi
total
asymptomat
patient
rsv
influenza
viru
infect
detect
rate
mean
asymptomat
patient
need
screen
detect
one
shedder
either
rsv
influenza
viru
studi
found
similar
preval
asymptomat
individu
influenza
rsv
use
rtpcr
campbel
et
al
examin
sampl
asymptomat
symptomat
patient
prior
hematopoiet
stemcel
transplant
hsct
studi
evalu
clinic
outcom
associ
respiratori
viru
detect
hsct
period
asymptomat
adult
pediatr
patient
screen
one
patient
rsv
none
influenza
viru
identifi
interestingli
studi
found
virus
eg
human
rhinoviru
coronaviru
patient
respiratori
virus
includ
screen
program
rare
caus
sever
lower
respiratori
tract
diseas
asymptomat
patient
test
posit
rsv
influenza
viru
studi
occupi
share
patient
room
time
viru
detect
major
move
singl
room
oneb
room
cohort
use
droplet
contact
precaut
use
affect
patient
isol
barrier
precaut
regard
viru
shedder
import
transmiss
roommat
describ
transfer
singl
oneb
room
challeng
case
due
lack
singleroom
avail
nonetheless
high
mortal
rate
rsv
influenza
infect
hematooncolog
patient
isol
barrier
precaut
enforc
measur
aim
lower
risk
patienttopati
transmiss
reduc
exposur
contact
patient
usag
droplet
contact
precaut
surgic
mask
gown
also
intend
reduc
exposur
hcw
hcw
whether
vaccin
influenza
wore
mask
perform
care
patient
rsv
influenza
viru
benefit
earli
detect
influenza
viru
possibl
earli
antivir
therapi
infect
patient
prophylaxi
antivir
agent
contact
patient
addit
effect
screen
program
associ
audit
feedback
talk
heighten
awar
among
hcw
visitor
respiratori
viral
infect
highli
suscept
immunocompromis
patient
popul
screen
period
nosocomi
cluster
influenza
viru
rsv
observ
two
ward
investig
limit
first
reli
virolog
laboratori
data
analyz
retrospect
inform
clinic
cours
outcom
patient
identifi
screen
access
studi
therefor
could
correl
laboratori
result
clinic
cours
patient
viral
load
estim
semiquantit
compar
ct
valu
realtim
pcr
posit
screen
followup
specimen
howev
approach
establish
respiratori
specimen
previou
studi
influenza
variou
pathogen
multifacet
approach
necessari
help
control
nosocomi
spread
rsv
influenza
healthcar
set
infect
control
base
standard
precaut
eg
complianc
hand
hygien
cough
etiquett
etc
togeth
rsv
influenza
pathogenspecif
precautionari
measur
eg
droplet
precaut
isol
special
highrisk
set
hematolog
oncolog
unit
addit
measur
use
lower
risk
hospit
acquisit
rsv
influenza
therefor
implement
prophylact
rtpcrbase
rsv
influenza
screen
program
target
asymptomat
patient
season
screen
program
enabl
us
identifi
patient
lack
symptom
respiratori
diseas
infect
either
rsv
influenza
period
month
patient
infect
control
practic
implement
symptomat
patient
rsv
influenza
infect
view
screen
program
prove
use
identifi
asymptomat
infect
patient
viral
shed
thu
reduc
risk
transmiss
potenti
nosocomi
cluster
rsv
influenza
viru
hematooncolog
ward
nevertheless
futur
studi
larger
cohort
includ
analys
clinic
data
necessari
valid
use
season
screen
program
suggest
author
declar
compet
interest
obtain
ethic
approv
studi
ethic
committe
hannov
medic
school
number
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
author
contribut
manuscript
accord
icmj
intern
committe
medic
journal
editor
recommend
ah
cb
respons
data
acquisit
author
involv
analysi
interpret
data
tg
ah
supervis
laboratori
diagnost
cb
fcb
prepar
manuscript
cb
organ
draft
process
cl
ab
mh
ft
implement
supervis
screen
program
ward
author
critic
revis
manuscript
account
accuraci
correct
author
read
agre
final
draft
submiss
acknowledg
technic
laboratori
staff
process
screen
specimen
